WHO and World Bank Group join forces to strengthen global health security

WHO and World Bank Group join forces to strengthen global health security

24 May 2018 – GENEVA – The World Health Organization (WHO) and World Bank Group today launched a new mechanism to strengthen global health security through stringent independent monitoring and regular reporting of preparedness to tackle outbreaks, pandemics, and other emergencies with health consequences. WHO Director-General Dr Tedros Adhanom Ghebreyesus and World Bank Group President […]

New Blockchain and AI-based Platform to Revolutionize Drug Discovery

New Blockchain and AI-based Platform to Revolutionize Drug Discovery

With an expected launch date of June 30, 2018, the new iPlexus will revolutionize the sharing of research work in preclinical life science research and drug discovery by giving researchers a secure, blockchain-and-AI-based platform for publishing and extending license to use unpublished data from successful and failed experiments. IP will be secured on the blockchain […]

FDA declines to approve Recro Pharma's non-opioid pain shot

FDA declines to approve Recro Pharma's non-opioid pain shot

The U.S. Food and Drug Administration on Thursday declined to approve Recro Pharma’s IV meloxicam noting the pain-relieving effect of the drug did not meet its expectations. A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. REUTERS/Jason Reed/File Photo The drug is a non-opioid injection to […]

The Transformation Agenda of the World Health Organization in the African Region: Delivering Achievements and …

The Transformation Agenda of the World Health Organization in the African Region: Delivering Achievements and …

The Regional Director is pleased to present this report on the achievements of the African Region in the first phase of the Transformation Agenda. The report reflects on the ongoing organizational reform that has delivered successful results and strengthened the Organization’s ability to carry out its mandate. This is especially relevant as 2018 also marks […]

A Wish for Nonexistent Cheap Drugs Is Not Standing to Sue

A Wish for Nonexistent Cheap Drugs Is Not Standing to Sue

Intellectual Property News The recent releases of highly effective, and highly priced, drugs to treat chronic diseases has bred a spate of efforts by activists to disenfranchise drug developers of their patent rights. One recent chapter is instructive, as it demonstrates how choosing the wrong venue for your patent challenge can doom it before it […]

Curaizon Using Big Data to Revolutionize the Pharmaceutical Industry

Curaizon Using Big Data to Revolutionize the Pharmaceutical Industry

The cost of some of the much-needed medication is often a big concern for national health services who are at times reluctant to pay the high prices charged for them. This means that some critically ill patients are given less effective medications that partly treat illness while causing numerous side effects – it is logical to […]

Swiss Group Suggests Switzerland Use Compulsory Licences To Curb Cancer Drug Prices

Swiss Group Suggests Switzerland Use Compulsory Licences To Curb Cancer Drug Prices

During a side event held alongside this week’s World Health Assembly, public health advocates proposed that Switzerland use compulsory licensing as a way to decrease what they said are exorbitant drug prices. Public Eye, a well-known Swiss non-governmental organisation, convened the side event at the 71th World Health Assembly, taking place from 21-26 May. On […]

Why medicine leads the professions in suicide, and what we can do about it

Why medicine leads the professions in suicide, and what we can do about it

Earlier this month, one of us visited a prominent U.S. medical school to give a lecture on the topic of burnout and how physicians can find more fulfillment in the practice of medicine. Sadly, that very day, a fourth-year medical student there took her own life. The problem was not personal failure. She had recently […]